RESUMEN
BACKGROUND: Melasma treatment remains challenging despite various laser systems available, because of potential side-effects and high recurrence rates. OBJECTIVE: Non-ablative fractionated photothermolysis (FP) is a promising therapeutic method, long-time results comparing treated vs. non-treated site are lacking. METHODS: A total of 14 patients were treated with FP in a split-face mode with standardized adjustments in three sessions (weeks 0, 3-4, 6-8, follow-up: 26-28). At each consultation, improvement was evaluated by patients and physicians. Objective assessment was performed using digital photographs and the pigment imaging tool SIAscope(®). RESULTS: Melasma improvement was registered in 83% and 75% of the cases 26-28 weeks after the first treatment based on two evaluations: by patient and by physician, respectively. Digital photography and SIAscope(®) revealed improvement in 54% and 85% after the first, 61% and 85% after the second, 41% and 58% after the third treatment, accordingly, mostly due to reduction of the outline sharpness. Patients with lighter skin complexions revealed significant improvement ranged from slight to moderate (P=0.03). Postinflammatory hyperpigmentation occurred in two cases with skin types III and IV. CONCLUSION: Non-ablative FP can be considered as a valuable treatment option with short-term improvement in terms of mild reduction and softening the edges of melasma in patients with skin types I/II, if prior topical therapies failed. Treatment of patients with skin types III+ should be critically questioned.
Asunto(s)
Melanosis/terapia , Fototerapia , Adulto , Femenino , Humanos , Persona de Mediana EdadRESUMEN
Today skin cancer is mainly treated by surgical interventions. New findings concerning molecular biology and the signaling pathways in epithelial skin cancers such as basal cell carcinoma, squamous cell carcinoma or melanoma, and mesenchymal skin cancers such as angiosarcoma and dermatofibrosarcoma protuberans (DFSP) have identified new molecular targets for a systemic or local treatment approach. For DFSP there is an opportunity already today to reduce the intensity of surgical procedures by pretreatment with targeted therapy. This article highlights important aspects in several skin cancer types.
Asunto(s)
Carcinoma Basocelular/tratamiento farmacológico , Carcinoma de Células Escamosas/tratamiento farmacológico , Dermatofibrosarcoma/tratamiento farmacológico , Melanoma/tratamiento farmacológico , Terapia Molecular Dirigida/métodos , Neoplasias Cutáneas/tratamiento farmacológico , Antineoplásicos/uso terapéutico , Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/cirugía , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/cirugía , Dermatofibrosarcoma/diagnóstico , Dermatofibrosarcoma/cirugía , Inhibidores Enzimáticos/uso terapéutico , Humanos , Melanoma/diagnóstico , Melanoma/cirugía , Transducción de Señal , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/cirugía , Investigación Biomédica TraslacionalRESUMEN
Vitamin D, ultraviolets and skin cancer The vitamin D supply is fundamental for the prevention of falls and fractures in aged people, among other effects. UVB triggers vitamin D synthesis in the skin. This relationship has recently gained attention both with the general public and with health care professionals. Some authors suggest a relaxation of UV protection measures, while others even advocate regular sunlight exposure in order to increase cutaneous vitamin D synthesis. However, the UV irradiation responsible for vitamin D synthesis also is a known carcinogen. UV exposure is an insufficient and harmful method to increase vitamin D synthesis. Oral supplementation is the recommended way to prevent and cure vitamin D deficiency.
Asunto(s)
Neoplasias Cutáneas/etiología , Piel/metabolismo , Rayos Ultravioleta/efectos adversos , Vitamina D/biosíntesis , Humanos , Luz Solar/efectos adversosRESUMEN
Approximately 5,000 of 6 million annual visitors of the Oktoberfest in Munich have to undergo medical treatment. Patients with alcohol intoxication without trauma or further complications are all treated in a specialized medical camp. We studied these patients in order to identify risk factors and to assess the relevance of the Glasgow Coma Score (GCS) and of ethanol blood concentrations for patient management. In 2004 totally 405 patients suffering from ethanol intoxication without trauma were treated in the medical camp. A complete set of the following data was obtained from all 405 patients: GCS, ethanol blood concentration, age, sex, blood pressure (mean, systolic and diastolic), body temperature, heart rate, blood sugar, GOT, gamma-GT, and CK. A multivariate logistic regression model was applied to identify risk factors predicting patients at increased risk of hospitalization. Low GCS (< or =8 vs. >8, OR: 4.18, CI: 1.96-8.65) low age (20-29 vs. > or =30 years, OR: 2.35, CI: 1.05-5.65) and male gender (male vs. female, OR: 3.58, CI: 1.36-9.34) independently predicted patients that had to be hospitalized. All other parameters including ethanol blood concentrations were not explanatory. Patients with GCS < or = 8 (n = 66) had a lower median blood pressure (P = 0.0312) and showed a smaller increase in blood pressure during the observation period compared to patients with GCS > 8 (P < 0.001), suggesting that this subgroup may require longer recovery periods. Men aged 20-29 years were at highest risk for hospital admission. Increased risk could not be explained by higher ethanol blood concentrations in this subgroup. Importantly, GCS < 6 does not justify endotracheal intubation in ethanol intoxicated patients, when further complications, such as trauma, can be excluded.